IP Library Granted Patent US 7,989,641
Granted Patent B2
US 7,989,641 · App. 12/537,764 · Granted Aug 2, 2011

Methods of synthesizing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,989,641
App. No.
12/537,764
Granted
Aug 2, 2011
Kind
B2
Abstract

The present disclosure relates to methods of synthesizing N-hydroxysuccinimidyl-carbonate intermediates from the corresponding sulfones useful in the preparation of 1-(acyloxy)-alkyl carbamate prodrugs.

Claims (28)

1. A method of synthesizing a 1-(acyloxy)alkyl N-hydroxysuccinimidyl carbonate compound of Formula (I) or a salt thereof comprising:

reacting a compound of Formula (V) or a salt thereof with an N-hydroxysuccinimidyl compound of Formula (VII) or a salt thereof to provide the corresponding compound of Formula (I) or a salt thereof:

wherein:

R 1 is chosen from C 1-6 alkyl, substituted C 1-6 alkyl, C 3-6 cycloalkyl, substituted C 3-6 cycloalkyl, phenyl, substituted phenyl, and C 7-9 phenylalkyl;

R 2 and R 3 are independently chosen from hydrogen, C 1-4 alkyl, substituted C 1-4 alkyl, C 1-4 alkoxycarbonyl, C 3-6 cycloalkyl, C 3-6 cycloalkoxycarbonyl, phenyl, substituted phenyl, and C 7-9 phenylalkyl; or R 2 and R 3 together with the carbon atom to which they are bonded form a ring chosen from a cyclobutyl, cyclopentyl, and cyclohexyl ring;

R 4 is chosen from C 1-4 alkyl and substituted C 1-4 alkyl wherein each of the one or more substituent groups is independently chosen from halogen, halo-C 1-3 alkyl, hydroxyl, and cyano;

each of R 5 , R 6 , R 7 , and R 8 is independently chosen from hydrogen, halogen, C 1-3 alkyl, and halo-C 1-3 alkyl; and

R 11 and R 12 are independently chosen from hydrogen, C 1-16 acylamino, C 1-16 acyloxy, C 1-6 alkoxycarbonylamino, C 1-6 alkoxycarbonyloxy, C 1-4 alkyl, substituted C 1-4 alkyl, C 1-6 alkoxy, substituted C 1-6 alkoxy, C 6-12 aryl, substituted C 6-12 aryl, C 7-16 arylalkyl, C 1-6 carbamoyl, C 1-6 dialkylamino, C 5-12 heteroaryl, hydroxyl, and sulfonamide; or R 11 and R 12 together with the atoms to which they are bonded form a ring chosen from a substituted C 3-12 cycloalkyl, substituted C 3-12 heterocycloalkyl, and substituted C 6-12 aryl ring.

2. The method of claim 1 , wherein the method comprises:

reacting the compound of Formula (I) or a salt thereof with a primary or secondary amine-containing drug of the formula HNR 9 R 10 or a salt thereof to provide a corresponding 1-(acyloxy)-alkyl carbamate compound of Formula (VI):

wherein —NR 9 R 10 is a moiety of a primary or secondary amine-containing drug.

3. The method of claim 1 , wherein R 1 is chosen from methyl, ethyl, n-propyl, isopropyl n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, neopentyl, 1,1,diethoxyethyl, phenyl, and cyclohexyl.

4. The method of claim 1 , wherein one of R 2 and R 3 is hydrogen; and the other of R 2 and R 3 is chosen from hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, phenyl, and cyclohexyl.

5. The method of claim 1 , wherein R 1 is isopropyl; R 2 is methyl; and R 3 is hydrogen.

6. The method of claim 1 , wherein R 1 is isopropyl; R 2 is isopropyl; and R 3 is hydrogen.

7. The method of claim 1 , wherein R 4 is chosen from C 1-4 alkyl, phenyl, and C 5-6 cycloalkyl.

8. The method of claim 1 , wherein R 4 is C 1-4 alkyl.

9. The method of claim 1 , wherein R 4 is methyl.

10. The method of claim 1 , wherein each of R 5 , R 6 , R 7 , and R 8 is hydrogen.

11. The method of claim 1 , wherein each of R 11 and R 12 is hydrogen.

12. The method of claim 1 , wherein R 11 and R 12 are independently chosen from acetoxy, isobutyroyloxy, pivaloyloxy, benzoyloxy, C 1-4 alkyl-substituted benzoyloxy, methoxy, and benzyloxy.

13. The method of claim 12 , wherein R 11 and R 12 are the same and are chosen from isobutyroyloxy and benzoyloxy.

14. The method of claim 1 , wherein one of R 2 and R 3 is hydrogen; and the other of R 2 and R 3 is chosen from hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, phenyl, and cyclohexyl; R 4 is chosen from C 1-4 alkyl, phenyl, and C 5-6 cycloalkyl; each of R 5 , R 6 , R 7 , and R 8 is hydrogen; and R 11 and R 12 are the same and are chosen from hydrogen, isobutyroyloxy, and benzoyloxy.

15. The method of claim 2 , wherein HNR 9 R 10 is chosen from gabapentin, pregabalin, R-baclofen, and tranexamic acid.

16. The method of claim 15 , wherein the compound of Formula (VI) is {[(1-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid or a salt thereof.

17. The method of claim 15 , wherein the compound of Formula (VI) is (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl)butanoic acid or a salt thereof.

18. The method of claim 15 , wherein the compound of Formula (VI) is 1-(R)-3-({[1-(2-methylpropanoyloxy)ethoxy]carbonylamino}methyl) (3S)-5-methylhexanoic acid or a salt thereof.

19. The method of claim 15 , wherein the compound of Formula (VI) is trans-4-({[(1R/S)-1-(2-methylpropanoyloxy)ethoxy]carbonylamino}methyl)-cyclohexanecarboxylic acid or a salt thereof.

Assignments (10)
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2021
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ARBOR PHARMACEUTICALS, LLC; WILSHIRE PHARMACEUTICALS, INC.; XENOPORT, INC.
Reel/Frame 057880/0174 →
SECURITY INTEREST Recorded Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2018
From: XENOPORT, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 046633/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
SECURITY INTEREST Recorded Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2013
From: GLAXO GROUP LIMITED
To: XENOPORT, INC.
Reel/Frame 029827/0366 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2010
From: LIU, PENG; DAI, QUNYING; YIN, HAO
To: GLAXO GROUP LIMITED
Reel/Frame 023738/0960 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2010
From: RAILLARD, STEPHEN P.; MANTHATI, SURESH K.
To: XENOPORT, INC.
Reel/Frame 023738/0991 →